Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 89

1.

HBsAg-negative mono-infection with hepatitis B virus genotype G.

Zaaijer HL, Boot HJ, van Swieten P, Koppelman MH, Cuypers HT.

J Viral Hepat. 2011 Nov;18(11):815-9. doi: 10.1111/j.1365-2893.2010.01397.x. Epub 2010 Nov 29.

PMID:
21114585
2.

Parvovirus B19 genotypes 1 and 2 detection with real-time polymerase chain reaction assays.

Koppelman MH, Rood IG, Fryer JF, Baylis SA, Cuypers HT.

Vox Sang. 2007 Oct;93(3):208-15.

PMID:
17845257
3.

No evidence of West Nile virus infection in Dutch blood donors.

Koppelman MH, Sjerps MS, de Waal M, Reesink HW, Cuypers HT.

Vox Sang. 2006 Apr;90(3):166-9.

PMID:
16507015
4.
5.

Multicenter performance evaluation of a transcription-mediated amplification assay for screening of human immunodeficiency virus-1 RNA, hepatitis C virus RNA, and hepatitis B virus DNA in blood donations.

Koppelman MH, Assal A, Chudy M, Torres P, de Villaescusa RG, Reesink HW, Lelie PN, Cuypers HT.

Transfusion. 2005 Aug;45(8):1258-66. Erratum in: Transfusion. 2005 Dec;45(12):1988.

PMID:
16078910
6.

Quantitative real-time detection of parvovirus B19 DNA in plasma.

Koppelman MH, Cuypers HT, Emrich T, Zaaijer HL.

Transfusion. 2004 Jan;44(1):97-103.

PMID:
14692974
7.

Sensitivity of HCV RNA and HIV RNA blood screening assays.

Lelie PN, van Drimmelen HA, Cuypers HT, Best SJ, Stramer SL, Hyland C, Allain JP, Moncharmont P, Defer C, Nübling M, Glauser A, da Silva Cardoso M, Viret JF, Lankinen MH, Grillner L, Wirthmüller U, Coste J, Schottstedt V, Masecar B, Dax EM.

Transfusion. 2002 May;42(5):527-36.

PMID:
12084160
8.

Sustained virological response in chronic hepatitis C patients after a 6- and a 36-month interferon-alpha2b treatment schedule: a multicenter, randomized, controlled study.

Damen M, Weegink CJ, Mauser-Bunschoten EP, Cuypers HT, Hermus MC, Sillekens P, Haan E, van den Berg HM, Bresters D, Lelie PN, Chamuleau RA, Reesink HW.

Scand J Gastroenterol. 2001 Jan;36(1):97-104.

PMID:
11218246
9.

A survey of liver pathology in needle biopsies from HBsAg and anti-HBe positive individuals.

ter Borg F, ten Kate FJ, Cuypers HT, Leentvaar-Kuijpers A, Oosting J, Wertheim-van Dillen PM, Honkoop P, Rasch MC, de Man RA, van Hattum J, Chamuleau RA, Tytgat GN, Jones EA.

J Clin Pathol. 2000 Jul;53(7):541-8.

10.

Implementation of HCV-NAT testing in The Netherlands.

Reesink HW, Cuypers HT, Lelie PN.

Dev Biol (Basel). 2000;102:105-7. No abstract available.

PMID:
10794096
11.

European multi-centre validation study of NucliSens Extractor in combination with HCV Amplicor 2.0 assay for HCV-NAT screening of plasma pools.

Cuypers HT, van Dijk R, Viret JF, Schottstedt V, Lankinen M, Da Silva Cardoso M, Lelie PN.

Biologicals. 1999 Dec;27(4):303-14.

PMID:
10686057
12.

Characterization of the quantitative HCV NASBA assay.

Damen M, Sillekens P, Cuypers HT, Frantzen I, Melsert R.

J Virol Methods. 1999 Sep;82(1):45-54.

PMID:
10507412
13.

Hepatitis G virus RNA and hepatitis G virus-E2 antibodies in Dutch hemophilia patients in relation to transfusion history.

Mauser-Bunschoten EP, Damen M, Zaaijer HL, Sjerps M, Roosendaal G, Lelie PN, Cuypers HT, van den Berg HM.

Blood. 1998 Sep 15;92(6):2164-8.

14.

Validation of a new immunoblot assay (LiaTek HIV III) for confirmation of human immunodeficiency virus infection.

Zaaijer HL, van Rixel GA, Kromosoeto JN, Balgobind-Ramdas DR, Cuypers HT, Lelie PN.

Transfusion. 1998 Aug;38(8):776-81.

PMID:
9709787
15.

Stability of hepatitis C virus RNA during specimen handling and storage prior to NASBA amplification.

Damen M, Sillekens P, Sjerps M, Melsert R, Frantzen I, Reesink HW, Lelie PN, Cuypers HT.

J Virol Methods. 1998 Jun;72(2):175-84.

PMID:
9694325
16.

Relation between laboratory test results and histological hepatitis activity in individuals positive for hepatitis B surface antigen and antibodies to hepatitis B e antigen.

ter Borg F, ten Kate FJ, Cuypers HT, Leentvaar-Kuijpers A, Oosting J, Wertheim-van Dillen PM, Honkoop P, Rasch MC, de Man RA, van Hattum J, Chamuleau RA, Reesink HW, Jones EA.

Lancet. 1998 Jun 27;351(9120):1914-8. Erratum in: Lancet 1999 Jul 17;354(9174):258. Lancet 1998 Jul 25;352(9124):328.

PMID:
9654258
17.

Detection of hepatitis C virus RNA: application to diagnostics and research.

Damen M, Cuypers HT.

Curr Stud Hematol Blood Transfus. 1998;(62):76-101. Review. No abstract available.

PMID:
9507805
18.

New hepatitis B virus mutant form in a blood donor that is undetectable in several hepatitis B surface antigen screening assays.

Jongerius JM, Wester M, Cuypers HT, van Oostendorp WR, Lelie PN, van der Poel CL, van Leeuwen EF.

Transfusion. 1998 Jan;38(1):56-9.

PMID:
9482395
19.

Stability of HIV-1 RNA in blood during specimen handling and storage prior to amplification by NASBA-QT.

Bruisten SM, Oudshoorn P, van Swieten P, Boeser-Nunnink B, van Aarle P, Tondreau SP, Cuypers HT.

J Virol Methods. 1997 Sep;67(2):199-207.

PMID:
9300385
20.

Performance of three generations of anti-hepatitis C virus enzyme-linked immunosorbent assays in donors and patients.

Vrielink H, Reesink HW, van den Burg PJ, Zaaijer HL, Cuypers HT, Lelie PN, van der Poel CL.

Transfusion. 1997 Aug;37(8):845-9.

PMID:
9280331
21.

High prevalence of hepatitis G virus after liver transplantation without apparent influence on long-term graft function.

Haagsma EB, Cuypers HT, Gouw AS, Sjerps MC, Huizenga JR, Slooff MJ, Jansen PL.

J Hepatol. 1997 Apr;26(4):921-5.

PMID:
9126808
22.

New anti-human immunodeficiency virus immunoblot assays resolve nonspecific western blot results.

Zaaijer HL, van Rixel T, van Exel-Oehlers P, Cuypers HT, Lelie PN.

Transfusion. 1997 Feb;37(2):193-8.

PMID:
9051095
23.

Evaluation of a new HTLV-I/II polymerase chain reaction.

Vrielink H, Zaaijer HL, Cuypers HT, van der Poel CL, Woerdeman M, Lelie PN, Winkel C, Reesink HW.

Vox Sang. 1997;72(3):144-7.

PMID:
9145484
24.

Look-back of anti-HCV ELISA-positive, HCV-RNA PCR-negative donors and recipients of their blood products.

Vrielink H, Reésink HW, Zaaijer HL, Scholten E, Kremer LC, Cuypers HT, Lelie PN, van Oers MH, van der Poel CL.

Vox Sang. 1997;72(2):67-70.

PMID:
9088071
25.

Risk of virus transmission by tissue, blood, and plasma products.

Lelie PN, Zaaijer HL, Cuypers HT.

Transplant Proc. 1996 Oct;28(5):2939. No abstract available.

PMID:
8908132
26.

International collaborative study on the second EUROHEP HCV-RNA reference panel.

Damen M, Cuypers HT, Zaaijer HL, Reesink HW, Schaasberg WP, Gerlich WH, Niesters HG, Lelie PN.

J Virol Methods. 1996 Apr 26;58(1-2):175-85.

PMID:
8783163
27.

Sensitivity and specificity of four assays to detect human T-lymphotropic virus type I or type I/II antibodies.

Vrielink H, Reesink HW, Zaaijer HL, van der Poel CL, Cuypers HT, Lelie PN.

Transfusion. 1996 Apr;36(4):344-6.

PMID:
8623137
28.

New strip immunoblot for the confirmation of HTLV-I/II infection.

Vrielink H, Zaaijer HL, Van der Poel CL, Quan S, Cuypers HT, Rios M, Lelie PN, Polito A, Sra K, DiNello R, Pichuantes S, Larson D, Reesink HW.

Vox Sang. 1996;70(2):114-6.

PMID:
8801759
29.

Reliability of the third-generation recombinant immunoblot assay for hepatitis C virus.

Damen M, Zaaijer HL, Cuypers HT, Vrielink H, van der Poel CL, Reesink HW, Lelie PN.

Transfusion. 1995 Sep;35(9):745-9.

PMID:
7570934
30.

Detection of HIV-1 RNA in plasma by isothermal amplification (NASBA) irrespective of the stage of HIV-1 infection.

Zaaijer HL, Kok W, ten Veen JH, Reesink HW, Foolen H, Winkel IN, Huisman JG, Cuypers HT, Kievits T, Lelie PN.

J Virol Methods. 1995 Mar;52(1-2):175-81.

PMID:
7769031
31.

Hepatitis C infection and viremia in Dutch hemophilia patients.

Mauser-Bunschoten EP, Bresters D, van Drimmelen AA, Roosendaal G, Cuypers HT, Reesink HW, van der Poel CL, van den Berg HM, Lelie PN.

J Med Virol. 1995 Mar;45(3):241-6.

PMID:
7539831
32.

Look-back study of infectivity of anti-HCV ELISA-positive blood components.

Vrielink H, van der Poel CL, Reesink HW, Zaaijer HL, Scholten E, Kremer LC, Cuypers HT, Lelie PN, van Oers MH.

Lancet. 1995 Jan 14;345(8942):95-6.

PMID:
7815889
33.

Performance of a new third-generation anti-hepatitis C virus ELISA (Monolisa anti-HCV new antigens) in various serum panels.

Vrielink H, Zaaijer HL, Reesink HW, Borst-Loef J, Cuypers HT, Lelie PN.

Vox Sang. 1995;69(3):257-8. No abstract available.

PMID:
8578742
34.

Hepatitis B-associated liver cirrhosis as an indication for liver transplantation.

Jansen PL, Haagsma EB, Klompmaker IJ, Cuypers HT, Karrenbeld A, Gouw AS, Slooff MJ.

Scand J Gastroenterol Suppl. 1995;212:19-22. Review.

PMID:
8578227
35.

Sensitivity and specificity of three third-generation anti-hepatitis C virus ELISAs.

Vrielink H, Zaaijer HL, Reesink HW, van der Poel CL, Cuypers HT, Lelie PN.

Vox Sang. 1995;69(1):14-7.

PMID:
7483486
36.

Hepatitis C virus six years on.

van der Poel CL, Cuypers HT, Reesink HW.

Lancet. 1994 Nov 26;344(8935):1475-9. Review. No abstract available.

PMID:
7968123
38.

Comparison of methods for detection of hepatitis B virus DNA.

Zaaijer HL, ter Borg F, Cuypers HT, Hermus MC, Lelie PN.

J Clin Microbiol. 1994 Sep;32(9):2088-91.

39.

The duration of fixation influences the yield of HCV cDNA-PCR products from formalin-fixed, paraffin-embedded liver tissue.

Bresters D, Schipper ME, Reesink HW, Boeser-Nunnink BD, Cuypers HT.

J Virol Methods. 1994 Jul;48(2-3):267-72.

PMID:
7989443
40.

Comparison of quantitative cDNA-PCR with the branched DNA hybridization assay for monitoring plasma hepatitis C virus RNA levels in haemophilia patients participating in a controlled interferon trial.

Bresters D, Cuypers HT, Reesink HW, Mauser-Bunschoten EP, van den Berg HM, Schaasberg WP, Wilber JC, Urdea MS, Neuwald P, Lelie PN.

J Med Virol. 1994 Jul;43(3):262-8.

PMID:
7931188
41.

Confirmation of hepatitis C infection: a comparison of five immunoblot assays.

Zaaijer HL, Vrielink H, van Exel-Oehlers PJ, Cuypers HT, Lelie PN.

Transfusion. 1994 Jul;34(7):603-7.

PMID:
7519796
42.

New immunoblot resolves indeterminate results for antibody to hepatitis C virus.

Zaaijer HL, Cuypers HT, Reesink HW, Lelie PN, Vrielink H, van der Poel CL.

Transfusion. 1994 Feb;34(2):184. No abstract available.

PMID:
8310494
43.

Detection of hepatitis C virus RNA: application to diagnostics and research.

Cuypers HT.

Curr Stud Hematol Blood Transfus. 1994;(61):49-68. Review. No abstract available.

PMID:
7956330
44.

Detection of HIV-1 DNA in leukocytes using a commercially available assay.

Zaaijer HL, Cuypers HT, Reesink HW, ten Veen JH, Schoon-Visser SC, Lelie PN.

Vox Sang. 1994;66(1):78-80.

PMID:
7908474
45.

Should the c100 antigen be removed from HCV antibody assays?

Zaaijer HL, Cuypers HT, Reesink HW, Lelie PN.

Vox Sang. 1994;66(2):150. No abstract available.

PMID:
7514326
46.

[Prevalence of human T-cell lymphotropic virus type I among Dutch blood donors].

Zaaijer HL, Dudok de Wit C, Cuypers HT, Winkel IN, Lelie PN.

Ned Tijdschr Geneeskd. 1993 Dec 4;137(49):2541-3. Dutch.

PMID:
8272141
47.

Recombinant immunoblot assay reaction patterns and hepatitis C virus RNA in blood donors and non-A, non-B hepatitis patients.

Bresters D, Zaaijer HL, Cuypers HT, Reesink HW, Winkel IN, van Exel-Oehlers PJ, van Drimmelen AA, Jansen PL, van der Poel CL, Lelie PN.

Transfusion. 1993 Aug;33(8):634-8.

PMID:
7688158
48.

Sexual transmission of hepatitis C virus.

Bresters D, Mauser-Bunschoten EP, Reesink HW, Roosendaal G, van der Poel CL, Chamuleau RA, Jansen PL, Weegink CJ, Cuypers HT, Lelie PN, et al.

Lancet. 1993 Jul 24;342(8865):210-1.

PMID:
8100931
49.

Variability of IgM response in hepatitis C virus infection.

Zaaijer HL, Mimms LT, Cuypers HT, Reesink HW, van der Poel CL, Taskar S, Lelie PN.

J Med Virol. 1993 Jul;40(3):184-7.

PMID:
7689091
50.

Reliability of polymerase chain reaction for detection of hepatitis C virus.

Zaaijer HL, Cuypers HT, Reesink HW, Winkel IN, Gerken G, Lelie PN.

Lancet. 1993 Mar 20;341(8847):722-4.

PMID:
8095626

Supplemental Content

Loading ...
Support Center